Launch of TerugBetaalRegeling Broxil®
The health insurer does not fully reimburse Broxil® 125 mg / 5 mL, powder for oral suspension. The producer of this medicine has...
Launch of TerugBetaalRegeling Acecort® en Fludrace®
The health insurer does not fully reimburse Acecort® 1mg and Fludrace® 62.5mcg. The producer of this medicine has therefore asked...
Termination TerugBetaalRegeling Xarelto®
Xarelto® is fully reimbursement from the 1st of January 2020. For this reason the co-payment is ended. Expenses from before the...
Termination TerugBetaalRegeling Invega®
Invega® is fully reimbursement from the 1st of December 2019. For this reason the co-payment is ended. Expenses from before the...
Specified overview health insurer
To consider and process an invoice of a GVS medicine, we need a specified overview of your healthcare costs issued by your health...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine